NanoViricides Inc.

NNVC | AMEX

Price Alert Chart Builder DCF Calculator

$1.65

-$0.04 (-2.37%)

Sep 22, 2026, 2:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.37%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $41.91M

1D Range

1.64 1.77

52W Range

0.85 2.23

Valuation (TTM)

PE -3.93

PB 0.00

EV/EBITDA 1.58

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target N/A

Cash Flow

FCF Yield -21670346.8%

SBC Adj. FCF Yield -21759135.0%

SBC Impact -0.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 29.9% | 7.5%

FCF 3Y | 5Y -150.0% | -100.0%

Returns

ROA -79.2%

ROE -92.7%

ROIC -89.3%

Financial Health

Net Cash

$3.21T

Current Ratio 3.17

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company'...

Sector Healthcare

Industry Biotechnology

Employees 7

IPO Date Oct 25, 2005

Website www.nanoviricides.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.